{"id":"https://openalex.org/W1965833191","doi":"https://doi.org/10.2174/156800705774933005","title":"Cannabinoids: Between Neuroprotection and Neurotoxicity","display_name":"Cannabinoids: Between Neuroprotection and Neurotoxicity","alternate_titles":[],"publication_year":2005,"publication_date":"2005-11-25","ids":{"openalex":"https://openalex.org/W1965833191","doi":"https://doi.org/10.2174/156800705774933005","mag":"1965833191","pmid":"https://pubmed.ncbi.nlm.nih.gov/16375685"},"language":"en","primary_location":{"id":"doi:10.2174/156800705774933005","doi":"https://doi.org/10.2174/156800705774933005","is_oa":false,"landing_page_url":"https://doi.org/10.2174/156800705774933005","pdf_url":null,"source":{"id":"https://openalex.org/S148418319","display_name":"CNS & Neurological Disorders - Drug Targets","issn_l":"1568-007X","issn":["1568-007X","1871-5273","1996-3181","2212-5299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Target -CNS &amp; Neurological Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1965833191"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069158259","display_name":"Yosef Sarne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yosef Sarne","raw_affiliation_strings":["Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel. sarney@post.tau.ac.il","Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel. sarney@post.tau.ac.il","institution_ids":["https://openalex.org/I16391192"]},{"raw_affiliation_string":"Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel,","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065631892","display_name":"Raphael Mechoulam","orcid":"https://orcid.org/0000-0002-6122-5698","observed_orcids":["https://orcid.org/0000-0002-6122-5698"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Raphael Mechoulam","raw_affiliation_strings":["Muerberger Chair inNeuropharmacology, Depatrment of Physiology and Pharmacology, SacklerFaculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.,Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Muerberger Chair inNeuropharmacology, Depatrment of Physiology and Pharmacology, SacklerFaculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.,Israel","institution_ids":["https://openalex.org/I16391192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5065631892"],"corresponding_institution_ids":["https://openalex.org/I16391192"],"apc_list":null,"apc_paid":null,"fwci":6.0598,"has_fulltext":false,"cited_by_count":134,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96956649,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"4","issue":"6","first_page":"677","last_page":"684"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cannabinoids","display_name":"cannabinoids","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9509999752044678},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9869999885559082},{"id":"https://openalex.org/keywords/delta9-tetrahydrocannabinol","display_name":"delta-9-tetrahydrocannabinol","score":0.9259999990463257},{"id":"https://openalex.org/keywords/anandamide","display_name":"anandamide","score":0.9309999942779541},{"id":"https://openalex.org/keywords/2-arachidonoylglycerol","display_name":"2-arachidonoylglycerol","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cb1-receptor","display_name":"CB1 receptor","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cb2-receptor","display_name":"CB2 receptor","score":1.0},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9213868379592896},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.8105471730232239},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.8009759783744812},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.6806187033653259},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6779628992080688},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.5465564131736755},{"id":"https://openalex.org/C2779783865","wikidata":"https://www.wikidata.org/wiki/Q410228","display_name":"Anandamide","level":5,"score":0.5352018475532532},{"id":"https://openalex.org/C46721173","wikidata":"https://www.wikidata.org/wiki/Q368952","display_name":"Endocannabinoid system","level":3,"score":0.5181837677955627},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49621397256851196},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.4736802875995636},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41293075680732727},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28044354915618896},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25329476594924927},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1594700813293457},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06256765127182007},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.06136423349380493},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.056685298681259155}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002186","descriptor_name":"Cannabinoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002186","descriptor_name":"Cannabinoids","qualifier_ui":"Q000506","qualifier_name":"poisoning","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009498","descriptor_name":"Neurotoxins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000506","qualifier_name":"poisoning","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/156800705774933005","doi":"https://doi.org/10.2174/156800705774933005","is_oa":false,"landing_page_url":"https://doi.org/10.2174/156800705774933005","pdf_url":null,"source":{"id":"https://openalex.org/S148418319","display_name":"CNS & Neurological Disorders - Drug Targets","issn_l":"1568-007X","issn":["1568-007X","1871-5273","1996-3181","2212-5299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Target -CNS &amp; Neurological Disorders","raw_type":"journal-article"},{"id":"pmid:16375685","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16375685","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets. CNS and neurological disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322252","display_name":"Israel Science Foundation","ror":"https://ror.org/04sazxf24"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W294065267","https://openalex.org/W2291878824","https://openalex.org/W1529724399","https://openalex.org/W4211058634","https://openalex.org/W1987823843","https://openalex.org/W7135762736","https://openalex.org/W7215950244","https://openalex.org/W2067020780","https://openalex.org/W2015987706","https://openalex.org/W2119898593"],"abstract_inverted_index":{"Cannabinoids,":[0],"such":[1],"as":[2,11,13],"the":[3,8,20,28,43,72,98,115,147],"delta9-tetrahydrocannabinol":[4],"(THC),":[5],"present":[6],"in":[7,48,54,104],"cannabis":[9],"plant,":[10],"well":[12],"anandamide":[14],"and":[15,33,50,76,143],"2-arachidonoyl":[16],"glycerol,":[17],"produced":[18],"by":[19,124,128],"mammalian":[21],"body,":[22],"have":[23],"been":[24],"shown":[25],"to":[26,34,52,93,136,144],"protect":[27],"brain":[29],"from":[30,108],"various":[31],"insults":[32],"improve":[35],"several":[36],"neurodegenerative":[37],"diseases.":[38],"The":[39,132],"current":[40,133],"review":[41,134],"summarizes":[42],"evidence":[44],"for":[45],"cannabinoid":[46,78,121],"neuroprotection":[47],"vivo,":[49],"refers":[51],"recent":[53],"vitro":[55],"studies,":[56],"which":[57],"help":[58],"elucidate":[59],"possible":[60],"molecular":[61],"mechanisms":[62,70],"underlying":[63],"this":[64,140],"protective":[65],"effect.":[66],"Some":[67],"of":[68,74,97],"these":[69],"involve":[71],"activation":[73],"CB1":[75],"CB2":[77],"receptors,":[79],"while":[80,103],"others":[81],"are":[82],"not":[83],"dependent":[84],"on":[85,100,111,139],"them.":[86],"In":[87,117],"some":[88],"cases,":[89],"protection":[90],"is":[91],"due":[92],"a":[94],"direct":[95],"effect":[96],"cannabinoids":[99],"neuronal":[101],"cells,":[102],"others,":[105],"it":[106],"results":[107],"their":[109],"effects":[110],"non-neuronal":[112],"elements":[113],"within":[114],"brain.":[116],"many":[118],"experimental":[119],"set-ups,":[120],"neurotoxicity,":[122],"particularly":[123],"THC,":[125],"resides":[126],"side":[127,129],"with":[130],"neuroprotection.":[131],"attempts":[135],"shed":[137],"light":[138],"dual":[141],"activity,":[142],"dissociate":[145],"between":[146],"two":[148],"contradictory":[149],"effects.":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1965833191","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
